Our findings are consistent with the research demonstrating an elevated concentration of total tau in patients with MS [31,32,33,34,35,36,37], whereas other studies showed no difference in tau concentrations between patients with MS and control subjects [38,39,40,41,42,43,44]. The gene discussed is MAPT; the disease is myeloid sarcoma.